Bianco I, Lerone M, Foglietta E, Deidda G, Cappabianca M P, Morlupi L, Ponzini D, Grisanti P, Di Biagio P, Amato A, Mezzabotta M, Graziani B
Associazione Nazionale per la Lotta contro le Microcitemie in Italia, Rome.
Haematologica. 1997 Sep-Oct;82(5):513-25.
beta thalassemia intermedia has its origins in compound heterozygosity for many different beta thal defects or in an interaction of a beta thal defect with altered alpha cluster. Two specific genetic associations (beta thal/beta(+) -101 C-->T and beta thal + alpha alpha alpha or alpha alpha alpha alpha) have been described in recent years as being determining a phenotype similar to that of simple beta thal heterozygote or, alternatively, a clinical picture of thalassemia intermedia.
A detailed study on this subject was carried out on 55 patients divided into 2 groups. Group I consisted of 20 patients, 17 of whom (Group Ia) had a beta thal/beta(+) -101 C-->T genotype and 3 (Group Ib) had a beta thal/beta IVS II-844 C-->G genotype. Group II consisted of 35 patients with beta thal association + alpha alpha alpha or alpha alpha alpha alpha. The methods of study have already been described in a previous issue.
Thirty percent of group Ia and 25% of group II were virtually asymptomatic, while the others presented the thalassemia intermedia phenotype. This second phenotype is generally milder in patients of group I and even less so in those of group II. In the former there is a higher level of HbF; in the second there is more marked alpha/beta + gamma globin synthesis imbalance. The severity of the phenotype has no connection with that of the beta thal defect. The patients of group Ib all presented thalassemia intermedia.
The definite clinical pictures of groups I and II are quite common in the Italian population and should therefore be well understood, especially for proper application of preventive measures against thalassemia major.
中间型β地中海贫血源于多种不同β地中海贫血缺陷的复合杂合性,或β地中海贫血缺陷与α基因簇改变之间的相互作用。近年来,已描述了两种特定的基因关联(β地中海贫血/β(+) -101 C→T和β地中海贫血+ααα或αααα),它们决定了与单纯β地中海贫血杂合子相似的表型,或者是中间型地中海贫血的临床表现。
对55例患者进行了关于该主题的详细研究,将其分为2组。第一组由20例患者组成,其中17例(第一a组)具有β地中海贫血/β(+) -101 C→T基因型,3例(第一b组)具有β地中海贫血/βIVS II - 844 C→G基因型。第二组由35例患有β地中海贫血关联+ααα或αααα的患者组成。研究方法已在前一期中描述。
第一a组30%和第二组25%的患者几乎无症状,而其他患者表现出中间型地中海贫血表型。这种第二种表型在第一组患者中通常较轻,在第二组患者中更轻。在前者中HbF水平较高;在后者中α/β+γ珠蛋白合成失衡更为明显。表型的严重程度与β地中海贫血缺陷的严重程度无关。第一b组的所有患者均表现出中间型地中海贫血。
第一组和第二组明确的临床表型在意大利人群中相当常见,因此应充分了解,特别是为了正确应用针对重型地中海贫血的预防措施。